Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIEOP RB 05 retinoblastoma diagnosis and therapy protocol
2006-005673-21Phase 3Terminated
- Sponsor
- Italian Association of Pediatric Hematology and Oncology
- Start
- Jun 2007
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of vincristine, carboplatin, doxorubicin, etoposide, ifosfamide and 1 more in retinoblastoma (Rb) (2 arms), sponsored by Italian Association of Pediatric Hematology and Oncology. Started Jun 2007; status: terminated.
02
Drugs
vincristinecarboplatindoxorubicinetoposideifosfamide
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on 2006-005673-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005673-21.